Weekly Rounds: ESBL-Producers, Home Infusion Therapy, Lowering SSIs, and More
Take 5 minutes to catch up on Infection Control Today®’s highlights for the week ending January 20, 2023.
Here are 5 highlights from Infection Control Today®'s (ICT®’s) wide-ranging coverage of the infection prevention and control world. Everything from interviews with known opinion leaders to the news that infection preventionists and other health care professionals can use on their jobs.
Preventing Infections in Cancer Patients at Home
Information for health care workers and patients to protect patients from infections.
Routine Change of Surgical Gloves/Instruments Significantly Lowers SSIs
A study clearly shows that surgical site infections (SSIs) can be reduced by changing surgical gloves and instruments before the closing abdominal wound closure.
Moderna: Vaccine Shown Effective Against RSV in Older Adults in Phase III Trial
Moderna announced encouraging news about its RSV mRNA-1345 vaccine and plans to submit for regulatory approval in the first half of 2023.
Considerations for Extended Spectrum Beta-Lactamase (ESBL)-Producers in Nursing Homes
Information for infection preventionists to manage ESBL-producers even while fighting against COVID-19.
Home Infusion Therapy: Study Shows Significant Lack of Formal Infection-Surveillance Training
New study shows home infusion therapy staff have significant barriers to infection-surveillance training, and this could be leading to higher infection rates.
Silent Saboteurs: Managing Endotoxins for Sepsis-Free Sterilization
Invisible yet deadly, endotoxins evade traditional sterilization methods, posing significant risks during routine surgeries. Understanding and addressing their threat is critical for patient safety.
